Efficacy of Empagliflozin As Add-on Therapy in Patients With Uncontrolled Type 2 Diabetes Mellitus. TAJ: J of Teachers Assoc 2023, 36 (1), 89-95. https://doi.org/10.3329/taj.v36i1.68304.